Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Lizanne Muller as president, EMEA operations

And Craig Boyd joins from Mayne Pharma as chief commercial officer

Lizanne MullerContract research organisation Envigo has appointed Lizanne Muller as president of its EMEA operations.

She brings 18 years’ experience working within a multinational pharmaceutical manufacturing company, with 16 years spent at the Dishman Group serving in a variety of roles of increasing responsibility, including vice president of compliance and governance.

In her new role Muller will be accountable for Envigo’s contract research services and research services models operations across Europe and Asia.

Envigo has also appointed Craig Boyd as chief commercial officer.

He has more than 20 years’ experience in various global pharmaceutical markets and was previously executive vice president of Mayne Pharma’s US specialty brands division.

Prior to this, Craig led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis.

Both will serve on the company’s executive committee and report to CEO Dr Adrian Hardy, who said both would bring great experience and knowledge to the firm.

He added: "Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

28th September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics